ABVC BioPharma, Inc. (ECOC) Free cash flow 2022–2024
ABVC BioPharma, Inc. (ECOC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.8MFY2024 · since FY2022: -$7.4M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.8M | +57.5% |
| FY2023 | -$4.3M | +41.9% |
| FY2022 | -$7.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating incomeECOC Operating marginECOC Operating cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Total liabilitiesECOC Shareholders’ equityECOC overview →